(4,5-bis(benzyloxy)pyridin-2-yl)methanamine | 1380110-19-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: (4,5-bis(benzyloxy)pyridin-2-yl)methanamine
• 英文别名: [4,5-Bis(phenylmethoxy)pyridin-2-yl]methanamine；[4,5-bis(phenylmethoxy)pyridin-2-yl]methanamine
• CAS: 1380110-19-9
• 化学式: C₂₀H₂₀N₂O₂
• 分子量: 320.391
• InChiKey: VTMHMIJJEXKWIP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  24
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  57.4
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (4,5-bis(benzyloxy)pyridin-2-yl)methanamine 在 dimethylsulfide borane complex 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 反应 24.0h， 生成 2-(((4,5-bis(benzyloxy)pyridin-2-yl)methyl)amino)ethan-1-ol
  参考文献：
  名称：

  NOVEL P62 LIGAND COMPOUND, AND COMPOSITION CONTAINING SAME FOR PREVENTING, AMELIORATING, OR TREATING PROTEINOPATHIES

  摘要：

  Novel p62 ligand compounds, or a stereoisomer, a solvate, a hydrate, or a prodrug thereof are disclosed. The novel compounds, stereoisomer, solvate, hydrate, or prodrug activates selective autophagy in cells to selectively remove proteins, organelles, and coagulations in the body, and thus can be advantageously used as a pharmaceutical composition for preventing, ameliorating, or treating various proteinopathies. Compositions such as pharmaceutical composition or food compositions containing the novel p62 ligand compounds, stereoisomer, solvate, hydrate, or prodrug thereof as well as uses thereof are disclosed.

  公开号：

  US20220402873A1
• 作为产物：
  描述：

  4,5-二苄氧基吡啶甲酸苄酯 在 sodium tetrahydroborate 、 氯化亚砜 、 乙醇 、 一水合肼 作用下， 以 乙醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 5.0h， 生成 (4,5-bis(benzyloxy)pyridin-2-yl)methanamine
  参考文献：
  名称：

  [EN] MONOBACTAMS
  [FR] MONOBACTAMES

  摘要：

  本发明涉及一类新的单环内酰胺衍生物及其用于治疗细菌感染的用途。

  公开号：

  WO2012073138A1

文献信息

• [EN] MONOBACTAMS<br/>[FR] MONOBACTAMES
  申请人：PFIZER

  公开号：WO2012073138A1

  公开（公告）日：2012-06-07

  The present invention is directed to a new class of monobactam derivatives and their use for treating bacterial infections.

  本发明涉及一类新的单环内酰胺衍生物及其用于治疗细菌感染的用途。
• MONOBACTAMS
  申请人：Brown Matthew F.

  公开号：US20120302542A1

  公开（公告）日：2012-11-29

  The present invention is directed to a new class of monobactam derivatives and their use for treating bacterial infections.
• Monobactams
  申请人：PFIZER INC.

  公开号：US20130252935A1

  公开（公告）日：2013-09-26

  The present invention is directed to a new class of monobactam derivatives and their use for treating bacterial infections.
• [EN] NOVEL P62 LIGAND COMPOUND, AND COMPOSITION CONTAINING SAME FOR PREVENTING, AMELIORATING, OR TREATING PROTEINOPATHIES<br/>[FR] NOUVEAU COMPOSÉ LIGAND P62 ET COMPOSITION LE CONTENANT POUR PRÉVENIR, ATTÉNUER OU TRAITER DES PROTÉINOPATHIES<br/>[KO] 신규한 p62 리간드 화합물, 이를 포함하는 단백질이상질환의 예방, 개선 또는 치료용 조성물
  申请人：AUTOTAC INC

  公开号：WO2021054804A1

  公开（公告）日：2021-03-25

  본 발명은 신규한 화학식 1의 p62 리간드 화합물, 이의 입체 이성질체, 용매화물, 수화물 또는 프로드럭, 이를 유효성분으로 포함하는 변형단백질환의 예방 또는 치료용 약학적 또는 식품 조성물에 관한 것으로, 본 발명에 따른 p62 리간드 화합물은 세포 내 선택적 오토파지를 활성화하여 체내 단백질, 소기관 및 응고체들을 선택적으로 제거함에 따라 다양한 단백질이상질환의 예방, 개선 또는 치료용 약학적 조성물로 유용하게 사용될 수 있다.
• NOVEL P62 LIGAND COMPOUND, AND COMPOSITION CONTAINING SAME FOR PREVENTING, AMELIORATING, OR TREATING PROTEINOPATHIES
  申请人：AUTOTAC INC.

  公开号：US20220402873A1

  公开（公告）日：2022-12-22

  Novel p62 ligand compounds, or a stereoisomer, a solvate, a hydrate, or a prodrug thereof are disclosed. The novel compounds, stereoisomer, solvate, hydrate, or prodrug activates selective autophagy in cells to selectively remove proteins, organelles, and coagulations in the body, and thus can be advantageously used as a pharmaceutical composition for preventing, ameliorating, or treating various proteinopathies. Compositions such as pharmaceutical composition or food compositions containing the novel p62 ligand compounds, stereoisomer, solvate, hydrate, or prodrug thereof as well as uses thereof are disclosed.